PolistenaB., SpandonaroF., CapraR., FantacciniS., SantoniL., ZimatoreG., & GasperiniC. (2019). The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study. Global & Regional Health Technology Assessment, 6(1). https://doi.org/10.33393/grhta.2019.463